Literature DB >> 9191010

MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.

J R Turner1, R D Odze, C P Crum, M B Resnick.   

Abstract

Recently, a novel tumor-associated protein, termed MN, has been described in carcinomas of the uterine cervix, where its expression has been shown to be associated with malignant transformation. Because malignant transformation in the esophagus develops through a dysplasia-carcinoma sequence similar to that which occurs in the cervix, this study was performed to evaluate MN expression in normal, preneoplastic, and neoplastic tissues of the esophagus. Esophageal tumor resection specimens from 27 patients (12 squamous cell carcinomas, one multifocal squamous dysplasia, 10 Barrett's-associated adenocarcinomas, two Barrett's esophagus with dysplasia, two adenosquamous carcinomas) were immunohistochemically stained with a monoclonal antibody (clone M75) directed against the MN antigen. The localization of MN antigen, as well as the proportion of positively stained cells, were determined in sections of normal, dysplastic, and carcinomatous tissues. The staining characteristics were correlated with the pathological features of the tumors. Weak intracellular MN expression was detected only in the basal cells of normal squamous epithelium. However, inflamed and reactive squamous epithelium showed increased staining in the basal layer and in the overlying mature squamous cells. MN expression was significantly increased in dysplastic squamous epithelium (P < .001). All esophageal squamous cell carcinomas (100%) stained positively for MN antigen, where the pattern of staining was predominantly membranous. However, the degree of MN staining did not correlate with any of the pathological features of the tumors. In Barrett's epithelium, MN stained positively in all types of metaplastic cells and showed no difference in dysplastic epithelium. In contrast to squamous cell carcinomas, only 80% of esophageal adenocarcinomas were positive for MN, but the degree of MN expression was inversely correlated with histological tumor differentiation (P < .015). The results of this study suggest that (1) the tumor-associated MN antigen may play a role in proliferation and regeneration in esophageal squamous epithelium, and (2) loss of MN expression may be related to cancer progression in Barrett's-associated adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191010     DOI: 10.1016/s0046-8177(97)90185-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.

Authors:  Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hiraki; Hirokazu Noshiro; Kohji Miyazaki
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.

Authors:  Minna Nortunen; Heikki Huhta; Olli Helminen; Seppo Parkkila; Joonas H Kauppila; Tuomo J Karttunen; Juha Saarnio
Journal:  Virchows Arch       Date:  2018-07-31       Impact factor: 4.064

3.  Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

Authors:  S Ivanov; S Y Liao; A Ivanova; A Danilkovitch-Miagkova; N Tarasova; G Weirich; M J Merrill; M A Proescholdt; E H Oldfield; J Lee; J Zavada; A Waheed; W Sly; M I Lerman; E J Stanbridge
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.

Authors:  C C Wykoff; N Beasley; P H Watson; L Campo; S K Chia; R English; J Pastorek; W S Sly; P Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Identification of a nuclear carbonic anhydrase in Caenorhabditis elegans.

Authors:  Teresa A Sherman; Sharath C Rongali; Tori A Matthews; Jason Pfeiffer; Keith Nehrke
Journal:  Biochim Biophys Acta       Date:  2012-01-05

Review 6.  Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.

Authors:  Emma Langella; Martina Buonanno; Giuseppina De Simone; Simona Maria Monti
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

7.  CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.

Authors:  Mijin Gu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

8.  Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.

Authors:  A Ingels; M Hew; F Algaba; O J de Boer; R J A van Moorselaar; S Horenblas; P Zondervan; J J M C H de la Rosette; M Pilar Laguna Pes
Journal:  World J Urol       Date:  2016-05-20       Impact factor: 4.226

9.  CO2 chemosensing in rat oesophagus.

Authors:  Y Akiba; M Mizumori; M Kuo; M Ham; P H Guth; E Engel; J D Kaunitz
Journal:  Gut       Date:  2008-08-05       Impact factor: 23.059

10.  Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.

Authors:  Ann Driessen; Willy Landuyt; Sylvia Pastorekova; Johnny Moons; Laurence Goethals; Karin Haustermans; Philippe Nafteux; Freddy Penninckx; Karel Geboes; Toni Lerut; Nadine Ectors
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.